http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5209771

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase I|Journal Article|Multicenter Study|Research Support, Non-U.S. Gov't
endingPage 571
issn 1432-0843
0344-5704
issueIdentifier 2
pageRange 563-571
publicationName Cancer Chemotherapy and Pharmacology
startingPage 563
bibliographicCitation Wakelee HA, Takimoto CH, Lopez-Anaya A, Chu Q, Middleton G, Dunlop D, Ramlau R, Leighl N, Rowinsky EK, Hao D, Zatloukal P, Jacobs CD, Rodon J. The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2012 Feb;69(2):563–71. doi: 10.1007/s00280-011-1772-z. PMID: 22057855.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8a4064a4b2ad2ab0c3655d0e7ef934a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d44b1ddbdc872461d017b55415321126
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5695-3474
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d79658fd2012975f2ae5d4459f1dff8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed32b197001e6d36bbfdf07aa8e6573a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_611af5d326608dac538167f8f9a4e08d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_15c7e98f80c2173e7d36cc89e435f02d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89b6c4d58a7337c34858e6f4a70914c3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aac2ca691a7575179127ea355a620e58
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21139612236dbf758b8868933a8a205c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_631c3a0f8a0361fa3a31a903a023caed
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d55e2469133868f6b48b6ce35ba82f8e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3199-2298
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dda363227a3bf49e69cc3f9f6d3014f4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_030e1563790c018f2fd21021189ce2cd
date 2011-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/22057855
https://doi.org/10.1007/s00280-011-1772-z
isPartOf https://portal.issn.org/resource/ISSN/0344-5704
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2664
https://portal.issn.org/resource/ISSN/1432-0843
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer
discusses http://id.nlm.nih.gov/mesh/M0018276
http://id.nlm.nih.gov/mesh/M0010246
http://id.nlm.nih.gov/mesh/M0250478
http://id.nlm.nih.gov/mesh/M0179294
http://id.nlm.nih.gov/mesh/M0021234
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9683
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44424639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID426756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46931011
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82146
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13200033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296871
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3d4216466641a66ae41510cb235ba416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3339
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5702198
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73265388

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129818107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128675752
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742546

Total number of triples: 61.